Daito Pharmaceutical Co.,Ltd. (TYO:4577)

Market Cap	39.09B +2.6%
Revenue (ttm)	50.65B +0.0%
Net Income	3.16B +65.7%
EPS	107.46 +71.3%
Shares Out	28.74M
PE Ratio	12.66
Forward PE	15.33
Dividend	45.00 (3.37%)
Ex-Dividend Date	May 28, 2026

Volume	36,400
Open	1,360.00
Previous Close	1,360.00
Day's Range	1,359.00 - 1,371.00
52-Week Range	1,120.00 - 1,521.00
Beta	0.19
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 14, 2026

About Daito Pharmaceutical

Daito Pharmaceutical Co.,Ltd. engages in the manufacture and sale of pharmaceutical products in Japan and internationally. It offers active pharmaceutical ingredients for generic drugs; develops and manufactures generic and over-the-counter drugs; and contract manufacturing services for ethical drugs. The company is also involved in the wholesale of pharmaceutical and veterinary medicine. It exports its products to the United States, as well as European and Asian countries. The company was formerly known as Daito Corporation and changed its nam...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1942
• Employees: 1,073
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4577

Financial Performance

In fiscal year 2026, Daito Pharmaceutical's revenue was 50.65 billion, an increase of 0.01% compared to the previous year's 50.64 billion. Earnings were 3.16 billion, an increase of 65.67%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 25, 2026

Data Sources Report a data error